PAR Pharmaceutical

NYSE: PRX

EST Feb 8 - 25.39USD
Get stock quotes, charts, etc.
ManagementAnnual ReportsNews ReleasesPresentations/WebcastsSEC Filings

About ParProductsInvestorsMediaCustomersCareers
Home / Investors / SEC Filings

Conventions and Exhibits
Key SEC filings for Par Pharmaceutical Companies, Inc.™ (and its predecessors) since December 31, 1994 can be accessed by opening appropriate web pages on the US Securities and Exchange Commission web site. Links are provided below by category.

* Every director, officer or owner of more than 10 percent of a class of equity securities registered under Section 12 of the 1934 Act must file with the Commission a statement of ownership regarding such security. The initial filing is on Form 3 and changes are reported on Form 4. The annual statement of beneficial ownership of securities is on Form 5. The forms contain information on the reporting person's relationship to the company and on purchases and sales of such equity securities. Interpretive responsibility for such filings rests with the Office of the Chief Counsel, Division of Corporation Finance, Securities and Exchange Commission.

 


Please contact investor relations with investment questions about Par.

Analyst coverage